Krystal Biotech, Inc. (KRYS)

250.89 -2.47 (-0.97%) USD  |  NASDAQ  |  Dec 24, 10:44
More

Krystal Biotech SG&A Expense (TTM): 136.75M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
DexCom, Inc. 1.297B
Alnylam Pharmaceuticals, Inc. 1.181B
Vanda Pharmaceuticals, Inc. 214.26M
ADMA Biologics, Inc. 96.37M
Aldeyra Therapeutics, Inc. 9.186M